Holder | Position | Change | Date | |
---|---|---|---|---|
Marshall Wace LLP | 0.9% | 0 | 10-Dec-2024 | View History |
Kintbury Capital LLP | 0.51% | 0 | 20-Nov-2024 | View History |
WorldQuant LLC | 0.5% | 0 | 20-Nov-2024 | View History |
Greenvale Capital LLP | 0.74% | 0 | 23-Oct-2024 | View History |
AKO Capital LLP | 1.22% | 0 | 15-Oct-2024 | View History |
Citadel Advisors LLC | 0.51% | 0 | 02-Aug-2024 | View History |
Smith & Nephew is a British medical technology company that develops, manufactures, and sells medical devices. Products include arthroscopy, trauma, clinical therapy, and orthopaedic reconstruction products. Smith & Nephew's products are sold in over 100 countries, including Europe, the Americas, Asia Pacific, the Middle East, and Africa.
Smith & Nephew operates in three segments: Orthopaedics, Sports Medicine & ENT, and Advanced Wound Management.
Smith & Nephew's shares are traded in London and New York, and the company is a constituent of the UK's FTSE100.
Smith and Nephew share price launched at 182p in 1988.